Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J.P. Morgan 2019: Biopharma Sentiment Soars As Deal And Financing Optimism Abounds

Executive Summary

Biopharma investor sentiment plunged at the end 2018, but soared as the J.P. Morgan Healthcare Conference kicked off with another big company acquisition and as industry participants indicated their optimism about financing and deal-making opportunities in 2019.

Advertisement

Related Content

J.P. Morgan Notebook Day 2: Biogen, GSK, Bluebird, Roche, Amgen, Biohaven, Lilly And FDA's Gottlieb
Bristol/Celgene Made Perfect Sense, But Doesn’t Promise Big M&A Year, EY Says
Lift-Off For Lilly In Cancer Genetics With Loxo Buy
Takeda's Weber: ‘Everything Relies On Our Ability To Deliver Innovative Medicines’
Bristol Values Celgene's Hematology, Immunology Portfolio At $74bn, But Does It Price In Risk?
Lilly Ready For More Risk When It Comes To Early Deals
Takeda To Press On With Core R&D Strategy Post-Shire
Adaptimmune Extends Funding Runway Ahead Of Clinical Results In Second Half
Sangamo Buys TxCell To Get In Early on CAR-Tregs In Immunology
Adaptimmune Hits High With TCR Platform Success With GSK Licensed Product

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel